For patients with coagulation dysfunction, such as thrombophilia (dysfunction of antithrombin III or proteins C) or patients who received stent implantation, life-long anticoagulation is always recommended. The gene discussed is SERPINC1; the disease is Rare hereditary thrombophilia.